From the American Medical Association
Reducing the addictiveness of cigarettes
Jack E Henningfield, Neal L Benowitz, John Slade, Thomas P Houston, Ronald M Davis, Scott D Deitchman, for the
Council on Scientific Affairs, American Medical
Association
OBJECTIVE
To assess the feasibility
of reducing tobacco-caused disease by gradually removing nicotine from
cigarettes until they would not be effective causes of nicotine addiction.
DATA SOURCES
Issues posed by such an
approach, and potential solutions, were identified from analysis of
literature published by the US Food and Drug Administration (FDA) in
its 1996 Tobacco Rule, comments of the tobacco industry and other
institutions and individuals on the rule, review of the reference lists
of relevant journal articles, other government publications, and
presentations made at scientific conferences.
DATA SYNTHESIS
The role of nicotine
in causing and sustaining tobacco use was evaluated to project the
impact of a nicotine reduction strategy on initiation and maintenance
of, and relapse to, tobacco use. A range of potential concerns and
barriers was addressed, including the technical feasibility of reducing
cigarette nicotine content to non-addictive levels, the possibility
that compensatory smoking would reduce potential health benefits, and
whether such an approach would foster illicit ("black market")
tobacco sales. Education, treatment, and research needs to enable a
nicotine reduction strategy were also addressed. The Council on
Scientific Affairs came to the following conclusions: (a) gradually
eliminating nicotine from cigarettes is technically feasible; (b) a
nicotine reduction strategy holds great promise in preventing
adolescent tobacco addiction and assisting the millions of current
cigarette smokers in their efforts to quit using tobacco products; (c)
potential problems such as compensatory over-smoking of denicotinised
cigarettes and black market sales could be minimised by providing
alternate forms of nicotine delivery with less or little risk to
health, as part of expanded access to treatment; and (d) such a
strategy would need to be accompanied by relevant research and
increased efforts to educate consumers and health professionals about
tobacco and health.
CONCLUSIONS
The council recommends
the following: (a) that cessation of tobacco use should be the goal for
all tobacco users; (b) that the American Medical Association continue
to support FDA authority over tobacco products, and FDA classification
of nicotine as a drug and tobacco products as drug-delivery devices;
(c) that research be encouraged on cigarette modifications that may
result in less addicting cigarettes; (d) that the FDA require that the
addictiveness of cigarettes be reduced within 5-10 years; (e) expanded
surveillance to monitor trends in the use of tobacco products and other
nicotine-containing products; (f) expanded access to smoking cessation
treatment, and strengthening of the treatment infrastructure; and (g)
more accurate labelling of tobacco products, including a more
meaningful and understandable indication of nicotine content.
Keywords: American Medical Association; addiction; nicotine; smoking cessation
© 1998 by Tobacco Control
Relevant Articles
- Taking aim at the bull's-eye: the nicotine in tobacco products
- CLIFFORD E DOUGLAS
Tob. Control 1998 7: 215-218.[Extract] [Full Text] [PDF]
- Dark secrets of tobacco company exposed
- TODD LEWAN
Tob. Control 1998 7: 315-319.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
-
Zeller, M., Hatsukami, D., and the Strategic Dialogue on Tobacco Harm Reducti,
(2009). The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US. Tobacco Control
18: 324-332
[Abstract] [Full Text] -
Fiore, M. C., Baker, T. B.
(2009). Stealing a March in the 21st Century: Accelerating Progress in the 100-Year War Against Tobacco Addiction in the United States. AJPH
99: 1170-1175
[Abstract] [Full Text] -
Benowitz, N. L., Dains, K. M., Hall, S. M., Stewart, S., Wilson, M., Dempsey, D., Jacob, P. III
(2009). Progressive Commercial Cigarette Yield Reduction: Biochemical Exposure and Behavioral Assessment. Cancer Epidemiol. Biomarkers Prev.
18: 876-883
[Abstract] [Full Text] -
Benowitz, N. L., Hall, S. M., Stewart, S., Wilson, M., Dempsey, D., Jacob, P. III
(2007). Nicotine and Carcinogen Exposure with Smoking of Progressively Reduced Nicotine Content Cigarette. Cancer Epidemiol. Biomarkers Prev.
16: 2479-2485
[Abstract] [Full Text] -
Connolly, G. N, Alpert, H. R, Wayne, G. F., Koh, H.
(2007). Trends in nicotine yield in smoke and its relationship with design characteristics among popular US cigarette brands, 1997 2005. Tobacco Control
16: e5-e5
[Abstract] [Full Text] -
Wang, S. N., Liu, Z., Tang, H. Z., Meng, J., Xu, P.
(2007). Characterization of environmentally friendly nicotine degradation by Pseudomonas putida biotype A strain S16. Microbiology
153: 1556-1565
[Abstract] [Full Text] -
Cummings, K M., Brown, A., Douglas, C. E
(2006). Consumer acceptable risk: how cigarette companies have responded to accusations that their products are defective. Tobacco Control
15: iv84-iv89
[Abstract] [Full Text] -
Gray, N, Henningfield, J E, Benowitz, N L, Connolly, G N, Dresler, C, Fagerstrom, K, Jarvis, M J, Boyle, P
(2005). Toward a comprehensive long term nicotine policy. Tobacco Control
14: 161-165
[Abstract] [Full Text] -
Dunsby, J, Bero, L
(2004). A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes. Tobacco Control
13: 362-369
[Abstract] [Full Text] -
Henningfield, J E, Benowitz, N L, Connolly, G N, Davis, R M, Gray, N, Myers, M L, Zeller, M
(2004). Reducing tobacco addiction through tobacco product regulation. Tobacco Control
13: 132-135
[Abstract] [Full Text] -
Sumner, W II
(2003). Estimating the health consequences of replacing cigarettes with nicotine inhalers. Tobacco Control
12: 124-132
[Abstract] [Full Text] -
Henningfield, J E, Moolchan, E T, Zeller, M
(2003). Regulatory strategies to reduce tobacco addiction in youth. Tobacco Control
12: i14-24
[Abstract] [Full Text] -
Davis, R. M
(2000). Moving tobacco control beyond "the tipping point". BMJ
321: 309-310
[Full Text] -
Gray, N.
(2000). Reflections on the saga of tar content: why did we measure the wrong thing?. Tobacco Control
9: 90-94
[Full Text] -
JOOSSENS, L., HAYES;, A., HENNINGFIELD, J. E, SLADE, J.
(1999). Eliminating the nicotine in cigarettes. Tobacco Control
8: 223-224
[Full Text] -
Bates, C., McNeill, A., Jarvis, M., Gray, N.
(1999). The future of tobacco product regulation and labelling in Europe: implications for the forthcoming European Union directive. Tobacco Control
8: 225-235
[Full Text] -
DAVIS, R. M
(1999). Tobacco Control: reflections on the first seven years. Tobacco Control
8: 1-9
[Full Text] -
SHATENSTEIN;, S., JARVIS, M. J, BATES;, C., LAUGESEN;, M., HENNINGFIELD, J. E, DAVIS, R. M, HOUSTON, T. P, BENOWITZ, N. L, SLADE;, J., DOUGLAS, C. E
(1999). Eliminating nicotine in cigarettes. Tobacco Control
8: 106-109
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
